MoFo Secures Summary Judgment Win for NeoGenomics Inc

Morrison Foerster secured summary judgment for NeoGenomics Inc. in the Middle District of North Carolina against Natera Inc.'s patent infringement lawsuit. Natera sued NeoGenomics in July 2023, claiming its RaDaR minimal residual disease assay infringed Natera's patents. The court previously issued a preliminary injunction removing the RaDaR assay from market. On August 28, 2025, Judge Catherine Eagles granted summary judgment invalidating all asserted patent claims under 35 U.S.C. § 101 for ineligible subject matter. The court will dismiss Natera's claims with prejudice and enter declaratory judgment of invalidity for both patents.